As of 2025-07-01, the EV/EBITDA ratio of Codiak BioSciences, Inc. (CDAK) is 0.34. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CDAK's latest enterprise value is -21.30 mil USD. CDAK's TTM EBITDA according to its financial statements is -62.43 mil USD. Dividing these 2 quantities gives us the above CDAK EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 16.2x | 13.6x |
| Forward P/E multiples | 10.7x - 25.3x | 15.5x |
| Fair Price | (9.52) - (11.80) | (10.54) |
| Upside | -16804.9% - -20810.2% | -18598.2% |
| Date | EV/EBITDA |